# Experience with Tirzepatide and Weight Management During and After a Clinical Trial in Japanese Patients with Obesity Disease: A Qualitative Study.

> PubMed lists PMID 42334799 in Advances in therapy as Journal Article, with publication-date metadata of 2026-06-23 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-42334799-tirzepatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-06-23
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42334799-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42334799-tirzepatide-v1.json
- Content SHA-256: `9805d30791a12c29c122868c23d2832714a34c4d0198600f530ebd14addef87c`

## Claims and source pins

### Headline

Experience with Tirzepatide and Weight Management During and After a Clinical Trial in Japanese Patients with Obesity Disease: A Qualitative Study. ([`pubmed-observation-pmid-42334799-2026-06-23-e4a6cca58758`](#source-pubmed-observation-pmid-42334799-2026-06-23-e4a6cca58758))

### Summary

PubMed lists PMID 42334799 in Advances in therapy as Journal Article, with publication-date metadata of 2026-06-23 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42334799-2026-06-23-e4a6cca58758`](#source-pubmed-observation-pmid-42334799-2026-06-23-e4a6cca58758))

### Paragraph 1

PubMed lists PMID 42334799 in Advances in therapy as Journal Article, with publication-date metadata of 2026-06-23 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-42334799-2026-06-23-e4a6cca58758`](#source-pubmed-observation-pmid-42334799-2026-06-23-e4a6cca58758))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42334799-2026-06-23-e4a6cca58758`](#source-pubmed-observation-pmid-42334799-2026-06-23-e4a6cca58758))

## Sources

<a id="source-pubmed-observation-pmid-42334799-2026-06-23-e4a6cca58758"></a>
- **Experience with Tirzepatide and Weight Management During and After a Clinical Trial in Japanese Patients with Obesity Disease: A Qualitative Study. · retained source version 1:2026-06-23:current:e4a6cca587584fd8b898738be612b59523ff80703228ba0cb82d9f14b1027c56** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42334799/) (`pubmed-observation-pmid-42334799-2026-06-23-e4a6cca58758`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Experience with Tirzepatide and Weight Management During and After a Clinical Trial in Japanese Patients with Obesity Disease: A Qualitative Study." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-42334799-tirzepatide-v1.json SHA-256: 9805d30791a12c29c122868c23d2832714a34c4d0198600f530ebd14addef87c.